Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China · Delayed Price · Currency is CNY 4.970
-0.070 (-1.39%)
Sep 11, 2026, 3:00 PM CST
SHA:600998 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 167,402 | 161,251 | 151,695 | 149,981 | 140,282 | 122,359 |
Other Revenue | 160.87 | 138.99 | 115.13 | 158.54 | 142.16 | 48.09 |
| 167,563 | 161,390 | 151,810 | 150,140 | 140,424 | 122,407 | |
Revenue Growth | 7.59% | 6.31% | 1.11% | 6.92% | 14.72% | 10.42% |
Cost of Revenue | 154,503 | 149,008 | 140,075 | 138,140 | 129,560 | 112,636 |
Gross Profit | 13,060 | 12,382 | 11,735 | 12,000 | 10,864 | 9,772 |
Selling, General & Admin | 8,586 | 8,078 | 7,229 | 7,193 | 6,637 | 6,097 |
Research & Development | 122.07 | 128.84 | 146.7 | 196.61 | 178.39 | 194.94 |
Other Operating Expenses | 507.47 | 416.82 | 413.07 | 425.65 | 98.16 | 293.01 |
Operating Expenses | 9,619 | 9,046 | 7,812 | 7,947 | 7,074 | 6,684 |
Operating Income | 3,441 | 3,336 | 3,923 | 4,053 | 3,790 | 3,087 |
Interest Expense | -1,107 | -1,014 | -1,284 | -1,318 | -1,221 | -1,145 |
Interest & Investment Income | 284.87 | 1,141 | 1,456 | 255.17 | 490.63 | 310.74 |
Currency Exchange Gain (Loss) | 3.66 | -11.22 | -0.81 | -4.34 | -17.05 | -6.65 |
Other Non Operating Income (Expenses) | -83.21 | -83.05 | -178.79 | -265.43 | -281.66 | -151.72 |
EBT Excluding Unusual Items | 2,540 | 3,369 | 3,915 | 2,721 | 2,760 | 2,094 |
Impairment of Goodwill | - | - | -10.85 | -1.18 | - | - |
Gain (Loss) on Sale of Investments | 148.99 | 36.79 | -98.35 | -78.4 | 1.44 | 1,235 |
Gain (Loss) on Sale of Assets | 8.92 | -251.08 | -425.83 | 5.11 | 45.67 | 6.72 |
Asset Writedown | - | - | - | - | - | -2.35 |
Other Unusual Items | 173.54 | 135.25 | 257.61 | 344.62 | 30.9 | 29.12 |
Pretax Income | 2,871 | 3,290 | 3,637 | 2,991 | 2,838 | 3,363 |
Income Tax Expense | 787.67 | 880.23 | 851.03 | 701.2 | 552.55 | 754.88 |
Earnings From Continuing Operations | 2,083 | 2,410 | 2,786 | 2,290 | 2,286 | 2,608 |
Minority Interest in Earnings | -73.52 | -154.72 | -279.05 | -115.62 | -200.57 | -160.05 |
Net Income | 2,010 | 2,255 | 2,507 | 2,174 | 2,085 | 2,448 |
Net Income to Common | 2,010 | 2,255 | 2,507 | 2,174 | 2,085 | 2,448 |
Net Income Growth | -26.79% | -10.07% | 15.33% | 4.27% | -14.84% | -20.38% |
Shares Outstanding (Basic) | 5,242 | 5,125 | 5,015 | 5,056 | 5,274 | 5,187 |
Shares Outstanding (Diluted) | 5,242 | 5,125 | 5,015 | 5,056 | 5,274 | 5,187 |
Shares Change | 2.95% | 2.19% | -0.81% | -4.14% | 1.68% | -2.84% |
EPS (Basic) | 0.38 | 0.44 | 0.50 | 0.43 | 0.40 | 0.47 |
EPS (Diluted) | 0.38 | 0.44 | 0.50 | 0.43 | 0.40 | 0.47 |
EPS Growth | -28.89% | -12.00% | 16.28% | 8.78% | -16.25% | -18.06% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2,268 | 2,039 | 2,107 | 3,699 | 2,743 | 2,073 |
Free Cash Flow Per Share | 0.43 | 0.40 | 0.42 | 0.73 | 0.52 | 0.40 |
Dividend Per Share | 0.200 | 0.200 | 0.200 | 0.194 | 0.186 | 0.112 |
Dividend Growth | 0% | 0% | 3.20% | 4.31% | 66.64% | -39.99% |
Gross Margin | 7.79% | 7.67% | 7.73% | 7.99% | 7.74% | 7.98% |
Operating Margin | 2.05% | 2.07% | 2.58% | 2.70% | 2.70% | 2.52% |
Profit Margin | 1.20% | 1.40% | 1.65% | 1.45% | 1.49% | 2.00% |
Free Cash Flow Margin | 1.35% | 1.26% | 1.39% | 2.46% | 1.95% | 1.69% |
EBITDA | 4,046 | 3,942 | 4,665 | 4,730 | 4,416 | 3,634 |
EBITDA Margin | 2.42% | 2.44% | 3.07% | 3.15% | 3.15% | 2.97% |
D&A For EBITDA | 605.36 | 605.98 | 742.35 | 676.96 | 626.41 | 547.21 |
EBIT | 3,441 | 3,336 | 3,923 | 4,053 | 3,790 | 3,087 |
EBIT Margin | 2.05% | 2.07% | 2.58% | 2.70% | 2.70% | 2.52% |
Effective Tax Rate | 27.43% | 26.76% | 23.40% | 23.45% | 19.47% | 22.45% |
Revenue as Reported | 167,563 | 161,390 | 151,810 | 150,140 | 140,424 | 122,407 |